An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis.

Background and aims: Hepatitis C virus (HCV) treatment is essential for eliminating HCV in people who inject drugs (PWID), but has limited coverage in resource‐limited settings. We measured the cost‐effectiveness of a pilot HCV screening and treatment intervention using directly observed therapy amo...

Full description

Bibliographic Details
Published in:Addiction Vol. 117; no. 2; pp. 411 - 425
Main Authors: Mafirakureva, Nyashadzaishe, Stone, Jack, Fraser, Hannah, Nzomukunda, Yvonne, Maina, Aron, Thiong'o, Angela W., Kizito, Kibango Walter, Mucara, Esther W. K., González Diaz, C. Inés, Musyoki, Helgar, Mundia, Bernard, Cherutich, Peter, Nyakowa, Mercy, Lizcano, John, Chhun, Nok, Kurth, Ann, Akiyama, Matthew J., Waruiru, Wanjiru, Bhattacharjee, Parinita, Cleland, Charles
Format: research tables/charts Journal Article
Published: Wiley-Blackwell Feb2022
Online Access:View this record in EBSCOhost